Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells: II. Signal Transduction Pathways Involved

dc.contributor.authorAltundag, Ergul Mutlu
dc.contributor.authorYilmaz, Ayse Mine
dc.contributor.authorSerdar, Belgin Sert
dc.contributor.authorJannuzzi, Ayse Tarbin
dc.contributor.authorKocturk, Semra
dc.contributor.authorYalcin, A. Suha
dc.date.accessioned2026-02-06T18:45:44Z
dc.date.issued2021
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractFlavonoids are phenolic substances with chemo-preventive and chemotherapeutic properties. They are widely found in fruits and vegetables. The polyphenols quercetin and curcumin have antioxidant, anti-inflammatory, anti-carcinogenic, and pro-apoptotic properties. They were successfully used against different human cancers, especially chronic myeloid leukemia cancer cells. We have previously investigated anti-proliferative and apoptotic effects of quercetin and curcumin combination in K562 cells. Our data showed that they had beneficial synergistic effects. Based on these findings, we aimed to clarify signaling pathways involved in synergistic combination treatment with quercetin and curcumin in these cells. Proteins were investigated by Western blotting and by confocal microscopy. Changes in several genes in 10 different pathways related to cell proliferation, apoptosis, cell cycle, inflammation, hypoxia and oxidative stress were observed. Combination of quercetin and curcumin was effective on genes that were particularly related to p53, NF-kappa B and TGF-alpha pathways. Down-regulatory (CDKN1B, AKT1, IFN-gamma) and up-regulatory (BTG2, CDKN1A, FAS) effects on genes and related protein expressions may provide a multi-targeted therapy potential for chronic myeloid leukemia cancer cells without affecting healthy cells.
dc.description.sponsorshipScientific and Technological Research Council of Turkey [215S184]
dc.description.sponsorshipThis work was supported by The Scientific and Technological Research Council of Turkey (Project no: 215S184) and Dr. Nejat F. Eczacibasi Medical Awards Fund.
dc.identifier.doi10.1080/01635581.2020.1767167
dc.identifier.endpage712
dc.identifier.issn0163-5581
dc.identifier.issn1532-7914
dc.identifier.issue4
dc.identifier.orcid0000-0001-7528-1845
dc.identifier.orcid0000-0003-0802-523X
dc.identifier.pmid32420759
dc.identifier.scopus2-s2.0-85085507168
dc.identifier.scopusqualityQ1
dc.identifier.startpage703
dc.identifier.urihttps://doi.org/10.1080/01635581.2020.1767167
dc.identifier.urihttps://hdl.handle.net/11129/13939
dc.identifier.volume73
dc.identifier.wosWOS:000535119200001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherRoutledge Journals, Taylor & Francis Ltd
dc.relation.ispartofNutrition and Cancer-An International Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectKappa-B
dc.subjectCycle
dc.subjectDeath
dc.subjectBioavailability
dc.subjectProducts
dc.subjectTargets
dc.subjectBtg2
dc.titleSynergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells: II. Signal Transduction Pathways Involved
dc.typeArticle

Files